JP2007528372A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007528372A5 JP2007528372A5 JP2006553216A JP2006553216A JP2007528372A5 JP 2007528372 A5 JP2007528372 A5 JP 2007528372A5 JP 2006553216 A JP2006553216 A JP 2006553216A JP 2006553216 A JP2006553216 A JP 2006553216A JP 2007528372 A5 JP2007528372 A5 JP 2007528372A5
- Authority
- JP
- Japan
- Prior art keywords
- molecule
- disease
- bond
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)(C)OC(CN(CCN(CC(*)=*)CC(OC(C)(C)C)=O)CCN(CC(OC(C)(C)C)=O)CC(OC(C)(C)C)=O)=O Chemical compound CC(C)(C)OC(CN(CCN(CC(*)=*)CC(OC(C)(C)C)=O)CCN(CC(OC(C)(C)C)=O)CC(OC(C)(C)C)=O)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/776,470 US7405320B2 (en) | 1998-06-22 | 2004-02-11 | Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| US10/776,470 | 2004-02-11 | ||
| PCT/US2005/004177 WO2005077071A2 (en) | 2004-02-11 | 2005-02-11 | Therapeutic and diagnostic conjugates for use with multispecific antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007528372A JP2007528372A (ja) | 2007-10-11 |
| JP2007528372A5 true JP2007528372A5 (cg-RX-API-DMAC7.html) | 2008-03-27 |
| JP5084267B2 JP5084267B2 (ja) | 2012-11-28 |
Family
ID=34860853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006553216A Expired - Fee Related JP5084267B2 (ja) | 2004-02-11 | 2005-02-11 | 多特異性抗体との使用のための治療および診断用コンジュゲート |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7405320B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1720575B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5084267B2 (cg-RX-API-DMAC7.html) |
| AU (2) | AU2005211754B2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2819492C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005077071A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8435529B2 (en) | 2002-06-14 | 2013-05-07 | Immunomedics, Inc. | Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy |
| US8877901B2 (en) | 2002-12-13 | 2014-11-04 | Immunomedics, Inc. | Camptothecin-binding moiety conjugates |
| US7591994B2 (en) | 2002-12-13 | 2009-09-22 | Immunomedics, Inc. | Camptothecin-binding moiety conjugates |
| US8491896B2 (en) * | 2002-06-14 | 2013-07-23 | Immunomedics, Inc. | Anti-pancreatic cancer antibodies |
| US8821868B2 (en) | 2002-06-14 | 2014-09-02 | Immunomedics, Inc. | Anti-pancreatic cancer antibodies |
| ES2524767T3 (es) * | 2002-06-14 | 2014-12-12 | Immunomedics, Inc. | Anticuerpo monoclonal humanizado HPAM4 |
| WO2003106497A1 (en) * | 2002-06-14 | 2003-12-24 | Immunomedics, Inc. | Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
| US9599619B2 (en) | 2002-06-14 | 2017-03-21 | Immunomedics, Inc. | Anti-pancreatic cancer antibodies |
| US7601351B1 (en) | 2002-06-26 | 2009-10-13 | Human Genome Sciences, Inc. | Antibodies against protective antigen |
| US7651689B2 (en) * | 2002-11-15 | 2010-01-26 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of applying ionization radiation for therapy of infections |
| US9005613B2 (en) | 2003-06-16 | 2015-04-14 | Immunomedics, Inc. | Anti-mucin antibodies for early detection and treatment of pancreatic cancer |
| US8652484B2 (en) * | 2004-02-13 | 2014-02-18 | Immunomedics, Inc. | Delivery system for cytotoxic drugs by bispecific antibody pretargeting |
| CN101171034B (zh) | 2005-03-03 | 2014-06-18 | 免疫医疗公司 | 人源化l243抗体 |
| US20060222592A1 (en) * | 2005-04-05 | 2006-10-05 | Clemens Burda | Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications |
| US20080171067A1 (en) * | 2007-01-17 | 2008-07-17 | Immunomedics, Inc. | Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites |
| US8067006B2 (en) | 2005-04-06 | 2011-11-29 | Immunomedics, Inc. | Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites |
| WO2007016466A2 (en) * | 2005-07-29 | 2007-02-08 | Sloan-Kettering Institute For Cancer Research | Single wall nanotube constructs and uses therefor |
| JP2009508090A (ja) * | 2005-08-31 | 2009-02-26 | イムノメディクス, インコーポレイテッド | 予め標的化されたポジトロン放出断層撮影画像化のためのf−18ペプチド |
| US20090226465A1 (en) * | 2005-10-31 | 2009-09-10 | Jackson David Y | Macrocyclic depsipeptide antibody-drug conjugates and methods |
| US7622128B2 (en) * | 2005-12-13 | 2009-11-24 | University Of Washington | Porphyromonas gingivalis 1435/1449 LPS as an immune modulator |
| EP2674440B1 (en) | 2005-12-16 | 2019-07-03 | IBC Pharmaceuticals, Inc. | Multivalent immunoglobulin-based bioactive assemblies |
| CN101506358B (zh) * | 2006-05-15 | 2013-07-17 | 免疫医学股份有限公司 | 使用偶合的抗体或抗体片段治疗人免疫缺陷病毒感染的方法和组合物 |
| CN101495022B (zh) | 2006-07-24 | 2011-09-07 | 皇家飞利浦电子股份有限公司 | 具有对周围组织的可变照明的胶囊摄像机 |
| CN101626787A (zh) * | 2007-01-19 | 2010-01-13 | 马林克罗特公司 | 诊断的和治疗的环氧合酶-2结合配体 |
| WO2009003188A2 (en) * | 2007-06-27 | 2008-12-31 | Cedars-Sinai Medical Center | N-terminal specific chemical labeling for proteomics applications |
| ES2551880T3 (es) * | 2007-09-20 | 2015-11-24 | Przedsiebiorstwo Produkcyjno-Consultingowe Adob Sp. Z O.O. Sp. K. | Un proceso para la preparación de ácido N,N'-bis(2-hidroxibencil)etilenodiamino-N,N'-diacético y sus derivados |
| WO2009146099A2 (en) | 2008-04-02 | 2009-12-03 | Georgia State University Research Foundation, Inc. | Contrast agents, methods for preparing contrast agents, and methods of imaging |
| EP2147683A1 (en) * | 2008-07-25 | 2010-01-27 | DKFZ Deutsches Krebsforschungszentrum | Construct and method for the internalization of cargo molecules into a cell |
| PL3912643T3 (pl) | 2009-02-13 | 2023-01-23 | Immunomedics Inc. | Immunokoniugaty z połączeniem rozszczepialnym wewnątrzkomórkowo |
| WO2011034660A1 (en) | 2009-09-16 | 2011-03-24 | Immunomedics, Inc. | Class i anti-cea antibodies and uses thereof |
| IN2012DN03354A (cg-RX-API-DMAC7.html) | 2009-12-02 | 2015-10-23 | Immunomedics Inc | |
| IN2012DN03177A (cg-RX-API-DMAC7.html) * | 2009-12-04 | 2015-09-25 | Immunomedics Inc | |
| EP2526421B1 (en) * | 2010-01-22 | 2018-11-21 | Immunomedics, Inc. | Detection of early-stage pancreatic adenocarcinoma |
| US8809282B2 (en) | 2010-05-06 | 2014-08-19 | Duke University | Method of reducing titers of antibodies specific for a therapeutic agent |
| EP2675485A4 (en) | 2011-02-15 | 2014-10-15 | Immunomedics Inc | ANTI-MUCIN ANTIBODY FOR THE EARLY RECOGNITION AND TREATMENT OF PANCREATIC CANCER |
| US9623117B2 (en) * | 2011-04-04 | 2017-04-18 | Wisconsin Alumni Research Foundation | Method for selective targeting and entry of bacterial toxins to cells |
| BR112013027224A8 (pt) | 2011-04-22 | 2018-08-14 | Emergent Product Dev Seattle | Proteínas de ligação de antígeno de membrana específico de próstata e composições e métodos relacionados |
| US9757458B2 (en) | 2011-12-05 | 2017-09-12 | Immunomedics, Inc. | Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells |
| AU2013302696B9 (en) | 2012-08-14 | 2018-08-09 | Ibc Pharmaceuticals, Inc. | T-cell redirecting bispecific antibodies for treatment of disease |
| US9382329B2 (en) | 2012-08-14 | 2016-07-05 | Ibc Pharmaceuticals, Inc. | Disease therapy by inducing immune response to Trop-2 expressing cells |
| CN107753954A (zh) | 2012-12-13 | 2018-03-06 | 免疫医疗公司 | 功效改进且毒性降低的抗体与sn‑38的免疫缀合物的剂量 |
| US9452228B2 (en) | 2013-04-01 | 2016-09-27 | Immunomedics, Inc. | Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2) |
| GB201314718D0 (en) * | 2013-08-16 | 2013-10-02 | Algeta As | Quantification method |
| ES2978993T3 (es) | 2014-02-21 | 2024-09-23 | Ibc Pharmaceuticals Inc | Terapia de enfermedades mediante la inducción de la respuesta inmunitaria a las células que expresan Trop-2 |
| PL3204018T3 (pl) | 2014-10-07 | 2022-01-03 | Immunomedics, Inc. | Neoadiuwantowe zastosowanie koniugatów przeciwciało-lek |
| WO2016161102A1 (en) * | 2015-04-02 | 2016-10-06 | The Research Foundation For The State University Of New York | A supramolecular chitosan complex drug delivery platform |
| EP3286224A4 (en) | 2015-04-22 | 2018-11-14 | Immunomedics, Inc. | Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells |
| PT3313443T (pt) | 2015-06-25 | 2023-08-30 | Immunomedics Inc | Combinação de anticorpos anti-hla-dr ou anti-trop-2 com inibidores de microtúbulos, inibidores de parp, inibidores de bruton quinase ou inibidores de fosfoinositídeo 3-quinase melhora significativamente o resultado terapêutico no cancro |
| PL3316885T3 (pl) | 2015-07-01 | 2021-12-06 | Immunomedics, Inc. | Immunokoniugaty przeciwciało-sn-38 z linkerem cl2a |
| HK1251480A1 (zh) | 2015-09-21 | 2019-02-01 | Aptevo Research And Development Llc | Cd3结合多肽 |
| US10758634B2 (en) | 2016-03-18 | 2020-09-01 | Wake Forest University | Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography |
| WO2018183586A1 (en) * | 2017-03-29 | 2018-10-04 | Purdue Research Foundation | Inhibitors of kinase networks and uses thereof |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2668165A (en) * | 1951-12-22 | 1954-02-02 | American Cyanamid Co | Condensation products of higher fatty acids, polyalkylene polyamines, and organic halides |
| US4468457A (en) | 1981-06-01 | 1984-08-28 | David M. Goldenberg | Method for producing a CSAp tryptic peptide and anti-CSAp antibodies |
| US4818709A (en) | 1983-01-21 | 1989-04-04 | Primus Frederick J | CEA-family antigens, Anti-CEA antibodies and CEA immunoassay |
| US4737453A (en) | 1984-12-12 | 1988-04-12 | Immunomedics, Inc. | Sandwich immunoassay utilizing a separation specific binding substance |
| US4735210A (en) | 1985-07-05 | 1988-04-05 | Immunomedics, Inc. | Lymphographic and organ imaging method and kit |
| US5776093A (en) | 1985-07-05 | 1998-07-07 | Immunomedics, Inc. | Method for imaging and treating organs and tissues |
| US5101827A (en) | 1985-07-05 | 1992-04-07 | Immunomedics, Inc. | Lymphographic and organ imaging method and kit |
| US5078998A (en) | 1985-08-02 | 1992-01-07 | Bevan Michael J | Hybrid ligand directed to activation of cytotoxic effector T lymphocytes and target associated antigen |
| US4792521A (en) | 1985-08-15 | 1988-12-20 | Immunomedics, Inc. | Non-enzymatic immunohistochemical staining system and reagents |
| US4863713A (en) | 1986-06-23 | 1989-09-05 | The Board Of Trustees Of Leland Stanford Jr. Univ. | Method and system for administering therapeutic and diagnostic agents |
| FR2604092B1 (fr) | 1986-09-19 | 1990-04-13 | Immunotech Sa | Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo |
| US5225541A (en) | 1987-03-05 | 1993-07-06 | Peralta Cancer Research Institute | Composition containing CEA/NCA-specific monoclonal antibody XMMBR-B14 conjugated to a detectable moiety and a kit containing the antibody |
| US4971792A (en) | 1987-03-27 | 1990-11-20 | The Wistar Institute | Monoclonal antibodies against glycolipid antigens |
| US5128119A (en) | 1989-06-12 | 1992-07-07 | Immunomedics, Inc. | Methods for technetium/rhenium labeling of f(ab1)2 fragments |
| US5541297A (en) * | 1988-04-01 | 1996-07-30 | Immunomedics, Inc. | Therapeutic conjugates of toxins and drugs |
| US5328679A (en) | 1988-04-01 | 1994-07-12 | Immunomedics, Inc. | Methods for technetium/rhenium labeling of proteins |
| US5851527A (en) | 1988-04-18 | 1998-12-22 | Immunomedics, Inc. | Method for antibody targeting of therapeutic agents |
| US5632990A (en) | 1988-04-22 | 1997-05-27 | Cancer Research Campaign Tech. Ltd. | Treatment for tumors comprising conjugated antibody A5B7 and a prodrug |
| US5183756A (en) | 1988-08-19 | 1993-02-02 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibody (D612) having selective reactivity for gastrointestinal caricinomas and method for employing the same |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| AU648022B2 (en) | 1989-03-14 | 1994-04-14 | Bionebraska, Inc. | Monoclonal antibodies for metallic cations on small molecules |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| FR2652004B1 (fr) | 1989-09-21 | 1994-10-28 | Immunotech Partners | Nouveaux derives hydrophiles, application au diagnostic et a la therapeutique, kits diagnostiques ou therapeutiques et reactifs immunologiques. |
| US5469854A (en) | 1989-12-22 | 1995-11-28 | Imarx Pharmaceutical Corp. | Methods of preparing gas-filled liposomes |
| EP0582595A1 (en) | 1991-04-26 | 1994-02-16 | Surface Active Limited | Novel antibodies, and methods for their use |
| DE4118120A1 (de) | 1991-06-03 | 1992-12-10 | Behringwerke Ag | Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung |
| US6027725A (en) | 1991-11-25 | 2000-02-22 | Enzon, Inc. | Multivalent antigen-binding proteins |
| CA2372813A1 (en) | 1992-02-06 | 1993-08-19 | L.L. Houston | Biosynthetic binding protein for cancer marker |
| US6096289A (en) | 1992-05-06 | 2000-08-01 | Immunomedics, Inc. | Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy |
| WO1993021940A1 (en) | 1992-05-06 | 1993-11-11 | Immunomedics, Inc. | Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| TW244342B (cg-RX-API-DMAC7.html) | 1992-07-29 | 1995-04-01 | Procter & Gamble | |
| ZA938243B (en) | 1992-11-12 | 1995-05-04 | Hybritech Inc | Altered affinity polypeptides of metal chelate binding antibodies |
| ATE199392T1 (de) | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
| US5336278A (en) * | 1993-05-13 | 1994-08-09 | The Lubrizol Corporation | Fuel composition containing an aromatic amide detergent |
| US5502037A (en) | 1993-07-09 | 1996-03-26 | Neuromed Technologies, Inc. | Pro-cytotoxic drug conjugates for anticancer therapy |
| IL113610A0 (en) | 1994-06-03 | 1995-08-31 | Immunomedics Inc | A method of radiolabeling a protein, radiolabeled proteins prepared thereby and diagnostic kits containing the same |
| US5746996A (en) | 1994-06-03 | 1998-05-05 | Immunomedics, Inc. | Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| DE4425857A1 (de) * | 1994-07-07 | 1996-01-11 | Schering Ag | Kaskaden-Polymer-Komplexe, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
| US5686578A (en) | 1994-08-05 | 1997-11-11 | Immunomedics, Inc. | Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| GB2293299A (en) | 1994-09-15 | 1996-03-20 | Ibm | Electric field emission reduction system |
| DE19508058A1 (de) * | 1995-02-21 | 1996-08-22 | Schering Ag | Verfahren zur Herstellung von DTPA-Tetraestern der terminalen Carbonsäuren und deren Verwendung zur Herstellung pharmazeutischer Mittel |
| DE19507822B4 (de) * | 1995-02-21 | 2006-07-20 | Schering Ag | Substituierte DTPA-Monoamide der zentralen Carbonsäure und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel |
| US5753206A (en) | 1995-06-07 | 1998-05-19 | Immunomedics, Inc. | Radiometal-binding analogues of luteinizing hormone releasing hormone |
| US6410690B1 (en) | 1995-06-07 | 2002-06-25 | Medarex, Inc. | Therapeutic compounds comprised of anti-Fc receptor antibodies |
| DE19525924A1 (de) * | 1995-07-04 | 1997-01-09 | Schering Ag | Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
| JP2759627B2 (ja) * | 1995-07-21 | 1998-05-28 | 東北大学長 | 非エステル結合性dtpa誘導体およびその製造方法 |
| DE19549286A1 (de) * | 1995-12-22 | 1997-06-26 | Schering Ag | Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
| US5874061A (en) * | 1995-12-22 | 1999-02-23 | Schering Aktiengesellschaft | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| DE19601060C2 (de) * | 1996-01-04 | 2002-04-25 | Schering Ag | Neue monofunktionalisierte EDTA-, DTPA- und TTHA-Derivate und deren Verwendung in der medizinischen Diagnostik und Therapie |
| AU717020B2 (en) | 1996-05-03 | 2000-03-16 | Immunomedics Inc. | Targeted combination immunotherapy of cancer |
| US5736120A (en) * | 1996-06-07 | 1998-04-07 | Srinivasan; Ananthachari | Method for preparing radiolabeled peptides |
| ATE380038T1 (de) | 1996-07-12 | 2007-12-15 | Immunomedics Inc | Radiometall-bindende peptide analoge |
| AU4119397A (en) | 1996-08-28 | 1998-03-19 | Viva Diagnostika Diagnostische Produkte Gmbh | Novel combination preparations and their use in immunodiagnosis and immunotherapy |
| US6004529A (en) * | 1997-04-11 | 1999-12-21 | Nycomed Imaging As | Chelating agents |
| DE69837095T2 (de) | 1997-09-03 | 2007-11-22 | Immunomedics, Inc. | Fluorierung von proteinen und peptiden für positronemissionstomographie |
| US6039773A (en) * | 1997-12-22 | 2000-03-21 | Chevron Chemical Company Llc | Fuel compositions containing polyamines of polyalkyl aromatic esters |
| US7074405B1 (en) | 1998-06-22 | 2006-07-11 | Immunomedics, Inc. | Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| US7138103B2 (en) * | 1998-06-22 | 2006-11-21 | Immunomedics, Inc. | Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| US6962702B2 (en) * | 1998-06-22 | 2005-11-08 | Immunomedics Inc. | Production and use of novel peptide-based agents for use with bi-specific antibodies |
| AU776910B2 (en) | 1998-12-08 | 2004-09-23 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Modifying protein immunogenicity |
| EP1411987A2 (en) * | 2001-07-31 | 2004-04-28 | Immunomedics, Inc. | Targeted polymeric delivery systems |
| CA2487692A1 (en) | 2002-05-29 | 2003-12-11 | Immunomedics, Inc. | Methods and compositions for radioimmunotherapy of brain and cns tumors |
| US20040022726A1 (en) | 2002-06-03 | 2004-02-05 | Goldenberg David M. | Methods and compositions for intravesical therapy of bladder cancer |
| JP4874090B2 (ja) * | 2003-01-31 | 2012-02-08 | イミューノメディクス、インコーポレイテッド | 治療薬および診断薬を投与するための方法および組成物 |
| CA2531118C (en) * | 2003-07-01 | 2013-01-08 | Immunomedics, Inc. | Multivalent carriers of bi-specific antibodies |
| JP4318985B2 (ja) * | 2003-08-21 | 2009-08-26 | 日本メジフィジックス株式会社 | ソマトスタチンアナログ誘導体およびその利用 |
| US7199268B2 (en) * | 2003-12-16 | 2007-04-03 | Schering Aktiengesellschaft | Process for the production of dendritic trimesic acid triamides |
-
2004
- 2004-02-11 US US10/776,470 patent/US7405320B2/en not_active Expired - Fee Related
-
2005
- 2005-02-11 WO PCT/US2005/004177 patent/WO2005077071A2/en not_active Ceased
- 2005-02-11 JP JP2006553216A patent/JP5084267B2/ja not_active Expired - Fee Related
- 2005-02-11 CA CA2819492A patent/CA2819492C/en not_active Expired - Fee Related
- 2005-02-11 EP EP20050726492 patent/EP1720575B1/en not_active Expired - Lifetime
- 2005-02-11 AU AU2005211754A patent/AU2005211754B2/en not_active Ceased
- 2005-02-11 CA CA2555666A patent/CA2555666C/en not_active Expired - Fee Related
-
2008
- 2008-06-12 US US12/138,065 patent/US8158573B2/en not_active Expired - Fee Related
-
2010
- 2010-12-09 AU AU2010249265A patent/AU2010249265C1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7330101B2 (ja) | ステロイド及びそのタンパク質コンジュゲート | |
| JP7121722B2 (ja) | 可溶性C5aRアンタゴニスト | |
| CA3103151A1 (en) | Compound having affinity substance to antibody and bioorthogonal functional group, or salt thereof | |
| KR20210152524A (ko) | 프로그램 가능한 중합체성 약물 | |
| KR20210152522A (ko) | 프로그램 가능한 중합체성 약물 | |
| CA3122135A1 (en) | Anti-claudin antibodies and uses thereof | |
| JP2006518737A5 (cg-RX-API-DMAC7.html) | ||
| JP2023510905A5 (cg-RX-API-DMAC7.html) | ||
| TWI755788B (zh) | 類鐸受體促效劑 | |
| JP2021500055A5 (cg-RX-API-DMAC7.html) | ||
| TW202110858A (zh) | 用於抑制精胺酸酶活性之組合物及方法 | |
| CA3063871A1 (en) | Cyclodextrin protein drug conjugates | |
| CN113164632A (zh) | 放射性免疫缀合物与检查点抑制剂组合疗法 | |
| CN1227500A (zh) | 药物复合物的制造方法 | |
| KR20160142392A (ko) | 튜부리신 유도체 | |
| JP2005517032A (ja) | 反応性ポリエチレングリコール部分を持つ細胞毒性薬剤、ポリエチレングリコール連結基を含んでなる細胞毒性コンジュゲート、ならびにその製造方法および使用方法 | |
| CN115427051B (zh) | 治疗剂及其结合物 | |
| JP2007528372A (ja) | 多特異性抗体との使用のための治療および診断用コンジュゲート | |
| JP2024521919A5 (cg-RX-API-DMAC7.html) | ||
| JP2025538358A (ja) | コンジュゲート反応に用いることが可能な化合物及びその複合体 | |
| JP2024150440A (ja) | 化合物及びその治療的使用 | |
| JP2019530707A (ja) | イソキノリジノベンゾジアゼピン(iqb)−1(クロロメチル)−2,3−ジヒドロ−1h−ベンゾ[e]インドール(cbi)二量体 | |
| JP2022518150A5 (cg-RX-API-DMAC7.html) | ||
| AU2023387509A1 (en) | An anti-tumor compound and use thereof | |
| WO2016144814A1 (en) | Synthesis and utility of new capgroup largazole analogs |